Skip to Content
Merck
CN

Gemfibrozil, stretching arms beyond lipid lowering.

Immunopharmacology and immunotoxicology (2009-08-22)
Avik Roy, Kalipada Pahan
ABSTRACT

Gemfibrozil is long known for its ability to reduce the level of triglycerides in the blood circulation and to decrease the risk of hyperlipidemia. However, a number of recent studies reveal that apart from its lipid-lowering effects, gemfibrozil can also regulate many other signaling pathways responsible for inflammation, switching of T-helper cells, cell-to-cell contact, migration, and oxidative stress. In this review, we have made an honest attempt to analyze various biological activities of gemfibrozil and associated mechanisms that may help to consider this drug for different human disorders as primary or adjunct therapy.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Gemfibrozil
Supelco
Gemfibrozil, Pharmaceutical Secondary Standard; Certified Reference Material
Gemfibrozil for system suitability, European Pharmacopoeia (EP) Reference Standard
Gemfibrozil, European Pharmacopoeia (EP) Reference Standard